Tumor hypoxia and anemia: Impact on the efficacy of radiation therapy

Seminars in Hematology

Volumn 37, Issue 4 SUPPL. 6, 2000, Pages 4-8

  Kumar, Parvesh ^a,b  

^a SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HEMOGLOBIN; MISONIDAZOLE; OXYGEN; RADIOSENSITIZING AGENT; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONFERENCE PAPER; HEAD CANCER; HEMOGLOBIN DETERMINATION; HUMAN; HYPERBARIC OXYGEN; HYPOXIA; IN VITRO STUDY; NECK CANCER; PELVIS CANCER; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; UROGENITAL TRACT CANCER;

EID: 0033790531     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/shem.2000.18116     Document Type: Conference Paper

References (24)

1. Cancer statistics, 1999
2. Ueber desensibilisierung gegen roentgen- und radiumstrahlen
3. X-ray sensitivity of E. coli as modified by oxygen tension
4. Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data
5. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome
6. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study
7. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx
8. Analysis of survival outcome and prognostic factors (PF) in the treatment of unresectable head and neck (H/N) squamous cell carcinoma (SCCa) using supradose intra-arterial targeted cisplatin (SIT-P) and concurrent radiation therapy (RT)
9. The impact of radiation related factors upon long term outcome in the management of advanced head and neck (H/N) squamous cell carcinoma (SCCa) treated with supradose intraarterial targeted (SIT) cisplatin (P) and radiation therapy (RT)
10. Clinical radiobiology of glottic T1 squamous cell carcinoma
11. T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control
12. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma
13. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study
14. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27
15. Hemoglobin, radiation, morbidity and survival
16. Preoperative radiotherapy for muscle-invasive bladder carcinoma: Long term follow-up and prognostic factors for 338 patients
17. Time-dose considerations in the treatment of anal cancer
18. The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate
19. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone
20. Oxygenation predicts radiation response and survival in patients with cervix cancer
21. Radiation therapy in the treatment of cervical cancer. The University of Chicago/Michael Reese Hospital Experience
22. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by RT: Results of a retrospective study of 386 patients
23. Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariable analysis of the effect of age, stage, histology, and blood counts on survival
24. The effect of anemia on the radiotherapy results of uterine cervix cancer